• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

MindBeacon Group Announces Series A Follow-on Investment round led by Green Shield Canada has Exceeded $18 Million

Share:

November 11, 2019

MindBeacon Group, owner and operator of the BEACON™ digital mental health platform and CBT Associates, one of Canada’s leading psychology clinic networks, has announced today an aggregate sum in excess of $18 million as part of a Series A follow-on investment round led by Green Shield Canada, with participation by Manulife, TELUS Ventures, and leading Canadian family offices.

The investment will propel MindBeacon Group further towards achieving its mission of making evidence-based mental health care more accessible to those who need it in Canada and beyond. The BEACON digital platform integrates one-on-one guidance by registered therapists in delivering clinical therapeutic interventions for several common mental health conditions including depression, anxiety, insomnia, and post-traumatic stress disorder (PTSD).

MindBeacon Group will focus on a planned expansion into new markets both within and outside Canada. The company will also finalize development of a licensed SaaS version of the therapy platform, for health organizations seeking to extend capacity of clinicians providing therapy while achieving effective outcomes. Since initial release of BEACON in 2017, MindBeacon Group has worked with a growing number of Canadian employers, insurers, and public sector health organizations to provide effective solutions for people struggling with mental health issues.

“We’re proud of how BEACON has already changed the Canadian mental healthcare landscape by helping thousands who would otherwise be unable to access evidence-based therapy due to stigma, affordability or difficulty seeing a qualified therapist in their region,” says Sam Duboc, Chair and CEO of MindBeacon Group. “With this investor funding, we’re excited to continue forward with expansion, so even more people challenged by mental health concerns can have the potential to live their best lives.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Green Shield Canada President and CEO, Zahid Salman, emphasizes that “Our investment in MindBeacon illustrates Green Shield Canada’s commitment to introducing new digital health innovations, helping more Canadians get access to quality mental health treatment, and aligning to our broader purpose of helping people live their healthiest lives.”

Source: Markets Insider

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Thermo Fisher Scientific to Acquire Qiagen N.V.Thermo Fisher Scientific to Acquire Qiagen N.V.
  • DelMar Announces Approval of Merger by StockholdersDelMar Announces Approval of Merger by Stockholders
  • Gamma Biosciences Acquires Controlling Stake in Mirus Bio to Expand Reach in Gene Therapy and Next Generation VaccinesGamma Biosciences Acquires Controlling Stake in Mirus Bio to Expand Reach in Gene Therapy and Next Generation Vaccines
  • Viewpoint Molecular Targeting Announces Transformational MergerViewpoint Molecular Targeting Announces Transformational Merger
  • FibroGen and HiFiBio Announce Transformative Partnership to Advance Next-Generation Therapies for Patients with Cancer and Autoimmune DiseaseFibroGen and HiFiBio Announce Transformative Partnership to Advance Next-Generation Therapies for Patients with Cancer and Autoimmune Disease
  • Relay Acquires IoT Cybersecurity Firm Cybeats Technologies Fortifying Critical Pandemic Device DeploymentsRelay Acquires IoT Cybersecurity Firm Cybeats Technologies Fortifying Critical Pandemic Device Deployments
  • Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma PlcChiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc
  • Supriya Lifescience Targets Rs 1,600 Crore RevenueSupriya Lifescience Targets Rs 1,600 Crore Revenue

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications